Table 2

- Evaluation of biomarkers levels in CKD and CVD in patients with LC and type 2 diabetes mellitus (N=500).

Risk factorsn (%)
Chronic renal disease (CKD)
FBG (mmol/L)
7 mmol/L to <7.7 mmol/L67(13.4%)
7.7 mmol/L to <8.9 mmol/L241(48.2%)*
8.9 mmol/L to <10 mmol/L166(33.2%)
≥10 mmol/L26(5.5%)
Blood pressure (systolic/diastolic)
<120/80 mm Hg (Normal)240(48.0%)
120/80 mm Hg (Elevated)230(46.0%)
>120/80 mm Hg (High)30(6.0%)
Serum creatinine (mg/dL)
Creatinine 1 mg/dL is normal eGFR155(31.0%)
Creatinine 2 mg/dL is a 50% decreasing in eGFR255(51.0%)*
Creatinine 4 mg/dL is a 70 to 85% decreasing in eGFR90(18.0%)
Creatine 8 mg/dL is a 90 to 95% decreasing in eGFR0
eGFR stages
G1 = 90 (Normal)55(11.0%)
G2 = 60 to 89 (Slightly reduced)100(20.0%)
G3a = 45 to 59 (Moderately to mildly decreased)255(51.0%)*
G3b = 30 to 44 (Moderately to severely reduced)90(18.0%)
G4 = 15 to 29 (Significantly decreased)0
G5 = 15 (Renal insufficiency)0
Urinary albumin-to-creatinine ratio mg/g
UACR1 <30 (Normal)140(28.0%)
UACR2 = 30 to 300 (Slightly elevated)300(60.0%)*
UACR3 >300 (Moderate increase or severely increased)60(12.0%)
Cardiovascular disease (CVD)
LDL-C (mmol/L)
<2.6 (Optimal)344(69.0%)
>4.11(Borderline high)156(31.0%)
HDL-C (mmol/L)
<1.04 (at risk)190(38.0%)
>1.6 (Desirable)310(62.0%)*
Total cholesterol (mmol/L)
<5.17 (Normal)190(38.0%)
5.17 to 6.18 (Borderline high)210(42.0%)*
>6.21 (High)100(20.0%)
Triglycerides (TG) (mmol/L)
<1.6 (Normal)180(36.0%)
1.6 to 5.6 (Moderately high)220(440.%)*
≥5.6 mmol/L (Very high)100(20.0%)
BMI (kg/m2)
18.5-25 (Normal)107(21.0%)
25.0-29.9 (Overweight)245(49.0%)*
>30 (Obese)150(30.0%)
hs-CRP(mg/L)
<1.0 (Low risk)106(21.0%)
1.0-3.0 (Moderate risk)245(47.0%)*
>3.0 (High risk)150(32.0%)

Values are frequency and percentage (%). FBG: fasting blood glucose, HDL-C: high density lipoprotein, LDL-C: low-density lipoprotein, hs-CRP: high-sensitivity C-reactive protein, BMI: body mass index, eGFR: estimated glomerular filtration rate.

  • * P≤0.05 was obtained from the Chi-square test.